CVS Health inches closer to its long-term leverage target, helped by Aetna margin recovery and disciplined cash use.

CVS Health's CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025. Performance was supporte...

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

CVS Health (CVS) closed the most recent trading day at $67.58, moving +1.15% from the previous trading session.

CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.

The P/B ratio helps to identify low-priced stocks with high growth prospects. USNA, CVS, PFE, STNE and PSFE are some such stocks.

CVS Health reportedly plans to invest $20 billion over the next 10 years to build a “tech-enabled consumer health experience” that will encompass the company, its vertically integrated businesses, ...

PM, CVS, ET, GSK and NWG, which offer high dividends and carry Zacks buy ranks, are strong picks for stability amid volatile market conditions of 2025.

CVS Health has shown impressive year-to-date performance, driven by strong Q1 results and strategic shifts in its business model. I reiterate a buy rating on CVS due to its low valuation, mixed tec...

CVS' turnaround may be here, given the seemingly stabilizing medical cost trends as similarly reported by its peers, with it triggering the moderating Medical Benefit Ratio. This is despite the sta...

President Donald Trump's first 100 days proved tumultuous for the stock market. Trump instituted tariffs in his bid to bring more manufacturing jobs back to the U.S. and shake up global trade.

CVS Health Corporation (NYSE:CVS ) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Company Participants David Joyner - President, Chief Executive Officer Tom Cowhey - Executive Vice Preside...

Evaluate the expected performance of CVS Health (CVS) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metri...

In the most recent trading session, CVS Health (CVS) closed at $65.45, indicating a +0.43% shift from the previous trading day.

CVS Health said on Friday it has cut bonuses for some employees because of its low profit levels last year, as the healthcare conglomerate grapples with higher costs across its Medicare plans.